- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Wednesday, 07 March 2007
-
Current Status:
Answered by Tom McCabe on 15 March 2007
To ask the Scottish Executive whether it is still its policy to disperse civil service jobs across Scotland.
Answer
The Scottish Executive remainscommitted to the policy of job dispersal. Dundee City has benefited from the location of over 130 posts underour relocation policy since 1999.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Tuesday, 27 February 2007
-
Current Status:
Answered by Lewis Macdonald on 13 March 2007
To ask the Scottish Executive what the average waiting time is for the NHS wheelchair service for children, broken down by NHS board.
Answer
This information is not heldcentrally. The department continues to work closely with wheelchair service managerson further improving the service. This work should incorporate the development ofnationally consistent data collection on waiting times and other relevant Key PerformanceIndicators.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Tuesday, 27 February 2007
-
Current Status:
Answered by Lewis Macdonald on 13 March 2007
To ask the Scottish Executive what the average waiting time is for the NHS wheelchair service for adults, broken down by NHS board.
Answer
This information is not heldcentrally. The department continues to work closely with wheelchair service managerson further improving the service. This work should incorporate the development ofnationally consistent data collection on waiting times and other relevant Key PerformanceIndicators.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Tuesday, 27 February 2007
-
Current Status:
Answered by Andy Kerr on 12 March 2007
To ask the Scottish Executive whether there is a shortage of immunoglobulin for intravenous use.
Answer
I refer the member to the answer to question S2W-31997 on 7 March 2007. All answers towritten parliamentary questions are available on the Parliament鈥檚 website, the searchfacility for which can be found at
http://www.scottish.parliament.uk/webapp/wa.search.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Tuesday, 27 February 2007
-
Current Status:
Answered by Andy Kerr on 12 March 2007
To ask the Scottish Executive whether there is a shortage of pooled plasma products.
Answer
I refer the member to the answer to question S2W-31997 on 7 March 2007. All answers towritten parliamentary questions are available on the Parliament鈥檚 website, the searchfacility for which can be found at
http://www.scottish.parliament.uk/webapp/wa.search.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Tuesday, 27 February 2007
-
Current Status:
Answered by Andy Kerr on 12 March 2007
To ask the Scottish Executive what impact the closure of the Scottish National Blood Transfusion Service鈥檚 Protein Fractionation Centre will have on the supply of plasma products.
Answer
I refer the member to the answer to question S2W-31997 on 7 March 2007. All answers towritten parliamentary questions are available on the Parliament鈥檚 website, the searchfacility for which can be found at
http://www.scottish.parliament.uk/webapp/wa.search.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Friday, 23 February 2007
-
Current Status:
Answered by Lewis Macdonald on 9 March 2007
To ask the Scottish Executive what the take-up rate has been, as a percentage of those eligible, for the Minor Ailment Scheme since its launch in July 2006.
Answer
Approximately 26% of those eligibleto register for the Minor Ailment Service were registered by the 31 January 2007.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Friday, 23 February 2007
-
Current Status:
Answered by Lewis Macdonald on 9 March 2007
To ask the Scottish Executive what publicity campaign it has undertaken about the Minor Ailments Scheme since its launch in July 2006.
Answer
The Scottish Executive providedpatient information leaflets and posters to all community pharmacies in Scotland whenthe Minor Ailment Service was launched in July 2006. Information has also been madeavailable through NHS24 and the NHS Helpline. In addition a number of NHSboards have undertaken local promotional activities.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Friday, 23 February 2007
-
Current Status:
Answered by Andy Kerr on 7 March 2007
To ask the Scottish Executive whether any Scottish National Blood Transfusion Service Protein Fractionation Centre products were used by the NHS during the recent period of voluntary suspension and, if so, by whom and for what purpose.
Answer
While production atthe Protein Fractionation Centre (PFC) was voluntarily suspended, products remainedlicensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and arange of PFC products were issued under MHRA approval. These products were for thetreatment of patients with clotting disorders, burns, and those who required antibodyreplacement and prophylaxis for a range of conditions.
- Asked by: Shona Robison, MSP for Dundee East, Scottish National Party
-
Date lodged: Friday, 23 February 2007
-
Current Status:
Answered by Andy Kerr on 7 March 2007
To ask the Scottish Executive what plans there are for any products still held by Scottish National Blood Transfusion Service鈥檚 Protein Fractionation Centre.
Answer
Following the Medicines andHealthcare products Regulatory Agency (MHRA) inspection in January 2006, adecision was taken by the Scottish Blood Transfusion Service not to issueproducts from the Protein Fractionation Centre (PFC) to NHS Scotland except inthe case of clinical need. The products still held at the PFC are unlikely tobe used as they were produced before this date.
However, some in-dateproducts will be retained as contingency stocks, but will only be issued withthe approval of the MHRA. These are mainly specific specialist hyper-immuneplasma products.
